Articles tagged with Clinical Trials
The Case Comprehensive Cancer Center has been selected as a Lead Academic Participating Site by the National Cancer Institute for a six-year grant worth $8.9 million. This renewal grant enables the center to provide patients with additional access to clinical trials through the National Clinical Trials Network.
A La Trobe University study has found significant levels of fatigue and poor brain function can persist after concussion, with implications for diagnosis and treatment of persistent post-concussion syndrome (PCS). The study used innovative brain technology to assess brain functioning in a way that has never been done before.
A trial remedy for racial disparities in early-stage lung and breast cancer treatment has shown nearly eliminating existing gaps. The intervention consisted of a real-time warning system, race-specific feedback, health equity training, and nurse navigators to reengage patients.
Researchers compared two cardiac resynchronization therapies in a pilot study, finding comparable rates of response between His bundle pacing and biventricular pacing. The study suggests that His bundle pacing may be a viable alternative for treating heart failure patients with electrical disturbances.
New trials suggest whole body MRI can diagnose cancer stage more quickly and accurately than standard imaging for colorectal and non-small cell lung cancers. This reduces treatment decision time from an average of 13 days to 8 days, while costs are lowered by nearly a quarter in some cases.
A phase I/II clinical trial of an enzyme-based treatment found reduced signs of disease and discomfort in participants with severe dry eye disease. The treatment, DNase, was shown to be safe and effective in improving corneal health and reducing symptoms.
A study led by Vanderbilt University Medical Center's Sheila Ridner found bioimpedance spectroscopy to be more accurate than a tape measure in identifying women at risk of developing lymphedema. The technology reduced rates of progression by approximately 10%, a clinically meaningful improvement.
A clinical trial found that all four tested sunscreen active ingredients (avobenzone, oxybenzone, octocrylene, and ecamsule) were detected in blood samples at levels exceeding the FDA's recommended toxicology threshold. The study's limitations include lack of exposure to heat, sunlight, or humidity, which may impact absorption rates.
A rare but potentially fatal infection of the genitals has been identified as a side effect of SGLT2 inhibitors, requiring immediate attention and surgical intervention. Awareness of this association can inform prescriber-patient discussions about appropriate diabetes therapy.
A clinical trial found that transcatheter aortic valve replacement (TAVR) is equivalent or potentially preferable to surgical aortic valve replacement (SAVR) for low-risk surgical patients. TAVR showed strong post-procedure benefits, including reduced re-hospitalizations and improved quality of life metrics at 30 days.
A new surgical technique using ultrasonic energy to seal pulmonary artery branches has been shown to reduce post-operative bleeding, complications, and pain in patients with lung cancer. The study's results have the potential to make this less invasive procedure more widely available, leading to faster recovery times for thousands of C...
A multi-site international trial has shown promise in reducing the incidence of thoracotomy conversion for VATS/robotic anatomical lung resection. The use of an ultrasonic vessel-sealing device resulted in fewer bleeding complications and a faster recovery time, with no postoperative bleeding from divided PA branches.
Researchers found that omitting chemotherapy in HER2 positive metastatic breast cancer can significantly shorten progression-free survival but not overall survival. The PERNETTA trial suggests that targeted therapy alone may be safe for patients with low-to-intermediate tumour burden.
Researchers found that radiotherapy after chemotherapy improved survival in patients with large tumours, with a 7-10% survival benefit at three and five years. This trial suggests that radiotherapy should be considered for these patients to balance cure rates with toxic side effects.
A national quality improvement programme in emergency bowel surgery failed to improve survival rates, with one in ten patients dying within 30 days. The trial tested 37 quality improvements, including more senior doctor involvement and better patient assessment, but found them too difficult to implement.
A Swiss study finds that individualized nutrition significantly benefits hospital patients, improving treatment outcomes and reducing serious complications. The trial, involving over 2,000 patients, showed a statistically significant reduction in mortality and complication rates.
A recent clinical trial found that longer hemodialysis sessions did not improve patient outcomes, while also highlighting the need for effective strategies to engage clinicians and patients in trials embedded within routine care. The study's findings suggest a pressing need for data-driven guidance in dialysis practice.
A randomized clinical trial found that employees with workplace wellness programs reported better health behaviors after 18 months, including more regular exercise and weight management. However, there were no significant differences in other health outcomes or employment metrics.
A recent study published in JAMA found that magic mouthwash significantly reduced pain from oral mucositis, a common side effect of radiation therapy for head and neck cancers. The treatment, which contains diphenhydramine, lidocaine, and antacids, was well-tolerated by patients and outperformed placebo.
A clinical trial using mesenchymal stromal cells from patient bone marrow shows significant improvements in pain levels and quality of life for osteoarthritis patients. The study, led by Sowmya Viswanathan and Jaskarndip Chahal, found that higher doses of MSCs resulted in more effective outcomes.
The REHEAL Glove is a flexible wound dressing that provides negative pressure therapy and allows early motion therapy during healing. It has successfully completed another key step on the road toward commercialization, earning national recognition for its potential to improve treatment of hand trauma.
The €50 million MOBILISE-D project aims to develop a system using small sensors to monitor mobility and assess health. It will enable personalized healthcare, predictive diagnosis, and improved treatment for conditions like COPD, Parkinson's disease, and multiple sclerosis.
The NIH has launched a Phase 1 clinical trial to evaluate the safety and immune response of an experimental universal influenza vaccine candidate. The vaccine, known as H1ssF_3928, is designed to induce immunity against diverse influenza subtypes by focusing on a portion of the virus that varies relatively little from strain to strain.
A randomized trial found that a plant-based whole food diet reduced gingival bleeding and increased vitamin D values in patients with gingivitis. The experimental group also experienced weight loss and showed significant benefits without changes to plaque values.
Dr. Samuel Huang receives the Pfizer/ACMG Foundation Clinical Genetics Combined Residency Fellowship Award to enhance his clinical research training and expertise in biochemical genetics and therapeutics. He aims to improve patient care through translational genomics and policy changes.
A new study published in Radiology found that bariatric embolization produces significant weight loss and reduces appetite for up to one year. The procedure involves blocking arteries with beads to suppress hunger-stimulating hormones. Researchers saw encouraging signs of metabolic changes, including improved quality of life.
A subgroup of patients with advanced BRCA- or PALB2-mutated pancreatic cancer showed sustained clinical responses to rucaparib, a PARP inhibitor. The treatment provided complete or partial responses and reduced tumor size in some instances.
A phase I clinical trial combining telomelysin and radiotherapy achieved an impressive 85% overall response rate (ORR) and complete tumor eradication in most patients. The therapy was safe and effective, even for elderly patients with health complications.
The anti-PD-1 monoclonal antibody pembrolizumab showed promising antitumor activity with durable responses in patients with pretreated, advanced small cell lung cancer (SCLC). The study found an objective response rate of 19.3% and a median progression-free survival of 2 months.
A phase I clinical trial and FDA expanded access program show LOXO-195, a next-generation TRK inhibitor, is safe and effective in patients with NTRK gene fusions resistant to first-generation TRK inhibitors. The study found that LOXO-195 induced responses in patients whose tumors had acquired specific mutations.
In a phase 3 randomized, double-blind, placebo-controlled trial, researchers found that B-cell depletion using rituximab over 12 months was not associated with clinical improvement in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The study, published in Annals of Internal Medicine, contradicts previous phas...
A combination of HDAC inhibitor entinostat and pembrolizumab showed clinical responses in patients with melanoma that had progressed on prior anti-PD-1 treatment. The study suggests that adding HDAC inhibition to anti-PD-1 therapy may increase the efficacy of immunotherapy by modulating the immune system.
A new experimental glioblastoma vaccine developed by Jefferson and Imvax has shown promising results in a phase Ib clinical trial. The treatment was found to slow tumor recurrence and prolong patient survival in patients with newly diagnosed glioblastoma multiforme.
A combination of ipilimumab and nivolumab demonstrated clinical benefit among patients with high-grade neuroendocrine carcinoma in a phase II clinical trial. The therapy showed an overall response rate of 24% and improved progression-free survival, offering new hope for this patient population.
A phase I clinical trial has found a new combination therapy to be well-tolerated in patients with recurrent high-grade gliomas, a disease historically under-funded. The treatment combines ADI-PEG20, pemetrexed and cisplatin, showing encouraging efficacy and paving the way for further research.
A new study evaluates the effectiveness of three home-based assessment methods to monitor cognitive function and decline in participants over 75. The results show that all approaches are feasible but with varying degrees of success, and suggest potential improvements in participant retention rates and reduced costs.
A systematic review suggests that vitamin C administration can decrease ICU length of stay by an average of 7.8%, with higher doses reducing duration by up to 8.6%. Vitamin C's role in energy metabolism and cardiovascular system makes it a promising intervention for critically ill patients.
A team of researchers has developed self-sustaining, bioengineered blood vessels that can safely integrate into the native circulatory systems of patients. The vessels, currently being tested in phase 3 clinical trials, offer a promising alternative to replacing damaged vessels with those from human donors or animals.
A large multicenter trial found that standard intermittent positive pressure ventilation did not reduce the risk of bronchopulmonary dysplasia (BPD) or death at 36 weeks postmenstrual age for extremely preterm infants. In contrast, sustained inflations did not appear beneficial in reducing BPD risk and mortality in this vulnerable popu...
The Annovera vaginal ring, approved by the FDA last August, is a self-inserted system that provides contraceptive efficacy for up to 13 cycles (1 year) of use. It has a Pearl index of 2.98, indicating only about three unintended pregnancies per 100 women in a year.
The I-ACQUIRE trial evaluates an intensive pediatric therapy to increase upper extremity skills, gross motor development, and cognition in infants with strokes under four weeks old. The study aims to transform clinical rehabilitation for thousands of newly diagnosed infant stroke victims annually.
A PLOS Special Collection explores new steps in clinical research for optimal TB treatment, driven by WHO and IRD-France sponsorship. Experts outline best practices for future clinical trials to inform policy guidance.
The collaboration identifies leadership, patient engagement, and community engagement as crucial factors in increasing accrual of racial and ethnic minorities in cancer trials. High-recruiting centers like Henry Ford Cancer Institute excel in engaging providers, building trust, and seeking input from minority patients and caregivers.
A study examining calcium intake found that higher intake was associated with a lower risk of progression to late AMD. However, the association between calcium intake and different stages of AMD was inconsistent.
Researchers at OHSU test video chat to stave off dementia in seniors, showing promise in improved cognitive tests. Social isolation is a major problem for seniors, and this study aims to identify healthy but isolated individuals and see if regular conversation can prevent age-related cognitive decline.
In patients without STEMI, immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure. Clearing arteries with PCI sooner after cardiac arrest may not necessarily reduce long-term brain damage and its key factor in survival.
The NRG-RTOG 0214 trial found that prophylactic cranial irradiation improved disease-free survival, decreased brain metastasis rates, but did not improve overall survival in patients with locally advanced non-small cell lung cancer. This suggests PCI may prolong OS in a subgroup without primary tumor surgery.
Results from the PARTNER 3 trial demonstrate that low-risk patients with severe aortic stenosis can significantly benefit from minimally invasive TAVR, leading to shorter recovery times and lower complication rates. This groundbreaking procedure has the potential to transform treatment options for patients with heart disease.
The final results of MOMENTUM 3 show that the HeartMate 3 left-ventricular assist device markedly reduced re-operation due to pump malfunctions, lowering risk of bleeding events and strokes. The study found significant reductions in pump-related thrombosis, strokes and mucosal bleeding compared to the previous generation of cardiac pumps.
A Cleveland Clinic-led study found that an absorbable antibiotic envelope can significantly reduce major infections in cardiac device implantations. The envelope was shown to cut the rate of infections by 40% compared to standard care.
Transcatheter aortic valve replacement (TAVR) significantly reduces the primary endpoint of death, stroke, and re-hospitalizations in patients with severe, symptomatic aortic stenosis at low surgical risk. TAVR also shows lower rates of mortality, stroke, and repeat hospitalizations compared to surgery.
In the multicenter clinical trial, TAVR showed superiority to open-heart surgery in low-risk patients with severe aortic stenosis. One-year mortality rates were significantly lower with TAVR, with 42 deaths vs 68 in the surgical group. The study also found shorter hospital stays and fewer strokes for TAVR patients.
A new study found that 40% of large-scale randomised controlled trials in the UK and US failed to produce any evidence on whether an educational intervention boosts academic attainment. The researchers evaluated 141 trials involving over one million students, which tested various schemes.
Research from the Cardiovascular Research Foundation will present latest data on PCI, imaging technologies, and TAVR at ACC.19. The study found that treatment with angiotensin-converting enzyme inhibitors or receptor blockers affects revascularization after percutaneous coronary intervention.
A QUT-led study found that improved hospital cleaning practices reduced healthcare-associated infections by 37% and decreased overall infection rates by 5.8%. The cleaning bundle was successful in improving thoroughness and showed promise in reducing vancomycin-resistant enterococci infections.
A study recommends innovative strategies to address underrepresentation of racial and ethnic minorities in clinical trials, highlighting the need for tailored approaches. The study identifies key components such as strategic engagement with providers, community leader engagement, and dedicated input from minority patients and caregiver...
A randomized clinical trial found that daily bathing with chlorhexidine (CHG) and nasal antibiotic mupirocin significantly reduced bloodstream infections and antibiotic-resistant bacteria in patients with medical devices. However, no significant benefit was seen for the overall population.
A randomized clinical trial examined two nutritional strategies: multinutrient supplementation and food-related behavioral activation therapy. The combination of both strategies showed promise in preventing new episodes of major depressive disorder among overweight and obese adults over one year.
A low-calorie fasting-mimicking diet has been shown to reduce intestinal inflammation and increase intestinal stem cells, promoting the expansion of beneficial gut microbiota. The study suggests that this regimen may have potential in mitigating inflammatory bowel disease (IBD) pathology.
A new study published in JAMA found that nutritional supplements do not prevent depression, but lifestyle coaching to improve diet and eating behavior may reduce the risk. Participants who received a healthy dietary behavioral therapy experienced a reduction in depressive episodes when attending recommended sessions.